Pep 27 and lytA in vancomycin-tolerant pneumococci

Journal of Microbiology and Biotechnology

Volumn 21, Issue 12, 2011, Pages 1345-1351

  Olivares, Alma ^a,b   Trejo, José Olivares ^b   Arellano Galindo, José ^a   Zuñiga, Gerardo ^c   Escalona, Gerardo ^a   Vigueras, Juan Carlos ^a   Marín, Paula ^a,c   Xicohtencatl, Juan ^a   Valencia, Pedro ^a   Velázquez Guadarrama, Norma ^a  

^a Federico Gómez Children's Hospital of México   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

LytA; Pep 27; Streptococcus pneumoniae; Tolerance; Vancomycin

Indexed keywords

CEFOTAXIME; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; N ACETYLMURAMOYLALANINE AMIDASE; PEPTIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CLONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; LYTA GENE; NONHUMAN; PEP27 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PHYLOGENY; PNEUMOCOCCAL INFECTION;

STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDES; PHYLOGENY; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN;

EID: 84855245939     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1105.05045     Document Type: Article

References (24)

1. Bourgeois, I., M. Pestel-Caron, J. F. Lemeland, J. L. Pons, and F. Caron. 2007. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci. Antimicrob. Agents Chemother. 51: 740-743.
2. Fernebro, J., I. Andersson, J. Sublett, E. Morfeldt, R. Novak, E. Tuomanen, et al. 2004. Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibioticinduced lysis and contributes to antibiotic tolerance. J. Infect. Dis. 189: 328-338.
3. Gundián, G. P., P. J. Barreto, M. Á. Rodríguez, R. A. Machado, E. Mora, and M. Lescay. 1998. Glicopeptidos. Acta Méd. 8: 54-57.
4. Haas, W., J. Sublett, D. Kaushal, and E. I. Tuomanen. 2004. Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance. J. Bacteriol. 186: 8463-8471.
5. Henriques Normark, B., R. Novak, A. Ortqvist, G. Lallenius, E. Tuomanen, and S. Normark. 2001. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin. Infect. Dis. 32: 552-558.
6. Henriques Normark, B. and S. Normark. 2002. Antibiotic tolerance in pneumococci. Clin. Microbiol. Infect. 8: 613-622.
7. Jayaraman, R. 2008. Bacterial persistence: Some new insights into an old phenomenon. J. Biosci. 33: 795-805.
8. Lanie, J. A., W. L. Ng, K. M. Kazmierczak, T. M. Andrzejewski, T. M. Davidsen, K. J. Wayne, et al. 2007. Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J. Bacteriol. 189: 38-51.
9. Li-Korotky, H. S., L. A. Kelly, O. Piltcher, P. A. Hebda, and W. J. Doyle. 2007. Evaluation of microbial RNA extractions from Streptococcus pneumoniae. J. Microbiol. Methods 68: 342-348.
10. Liu, H. H. and A. Tomasz. 1985. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J. Infect. Dis. 152: 365-372.
11. McCullers, J. A., B. K. English, and R. Novak. 2000. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J. Infect. Dis. 181: 369-373.
12. McEllistrem, M. C., J. Stout, and L. H. Harrison. 2000. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. J. Clin. Microbiol. 38: 351-353.
13. Mitchell, L. and E. Tuomanen. 2001. Vancomycin-tolerant Streptococcus pneumoniae and its clinical significance. Pediatr. Infect. Dis. J. 20: 531-533.
14. Novak, R., B. Henriques, E. Charpentier, S Normark, and E. Tuomanen. 1999. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 399: 590-593.
15. Novak, R., E. Charpentier, J. S. Braun, and E Tuomanen. 2000. Signal transduction by a death signal peptide: Uncovering the mechanism of bacterial killing by penicillin. Mol. Cell 5: 49-57.
16. Ortega, M., F. Marco, A. Soriano, E. García, J. A. Martínez, and J. Mensa. 2003. Lack of vancomycin tolerance in Streptococcus pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001. Antimicrob. Agents Chemother. 47: 1976-1978.
17. Obregón, V., P. García, E. García, A. Fenoll, R. López, and J. L. García. 2002. Molecular peculiarities of the lytA gene isolated from clinical pneumococcal strains that are bile insoluble. J. Clin. Microbiol. 40: 2545-2554.
18. Word Health Organization. 2003. Pneumococcal vaccines. Wkly. Epidemiol. Rec. 78: 110-119.
19. National Committee for Clinical Laboratory Standards. 2005. Performance Standards for Susceptibility Testing; Fifteenth Informational Supplement M100-S15. NCCLS, Wayne, PA.
20. Rodriguez, C. A., R. Atkinson, W. Bitar, C. G. Whitney, K. M. Edwards, L. Mitchell, et al. 2004. Tolerance to vancomycin in pneumococci: Detection with a molecular marker and assessment of clinical impact. J. Infect. Dis. 190: 1481-1487.
21. Rohlf, F. J. 1998. Numerical taxonomy and multivariate analysis system. Exeter Software Inc., New York, N. Y
22. Sneath, P. H. A. and R. R. Sokal. 1973. Taxonomic structure, pp. 188-305. In: Numerical Taxonomy. W. H. Freeman & Co., San Francisco, CA.
23. Sung, H., H. B. Shin, M. N. Kim, K. Lee, E. C. Kim, W. Song, et al. 2006. Vancomycin-tolerant Streptococcus pneumoniae in Korea. J. Clin. Microbiol. 44: 3524-3528.
24. Villaseñor-Sierra, A., M. Lomas-Bautista, S. Aguilar-Benavides, and G. Martinez-Aguilar. 2008. Serotypes and susceptibility of Streptococcus pneumoniae strains isolated from children in Mexico. Salud Pública Méx. 50: 330-333.